UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 80.00
0.00 (0.00%)
Mar 24, 2026, 1:30 PM CST
UnicoCell Biomed Revenue
In the year 2025, UnicoCell Biomed had annual revenue of 30.10M TWD, down -5.58%. UnicoCell Biomed had revenue of 6.36M in the quarter ending December 31, 2025, a decrease of -41.33%.
Revenue
30.10M
Revenue Growth
-5.58%
P/S Ratio
169.12
Revenue / Employee
n/a
Employees
27
Market Cap
5.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.10M | -1.78M | -5.58% |
| Dec 31, 2024 | 31.88M | 7.29M | 29.66% |
| Dec 31, 2023 | 24.59M | 10.19M | 70.79% |
| Dec 31, 2022 | 14.40M | 6.22M | 76.07% |
| Dec 31, 2021 | 8.18M | 4.20M | 105.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.37B |
| Panion & Bf Biotech | 2.06B |
| Medigen Biotechnology | 1.58B |
| BioGend Therapeutics | 222.34M |
| Pharmosa Biopharm | 67.27M |
| OBI Pharma | 58.58M |
| AnnJi Pharmaceutical | 23.85M |
| Energenesis Biomedical CO.,LTD. | 7.67M |